
Choosing a veterinary hematology analyzer requires more than comparing instrument specifications. For technical evaluators, the critical questions are whether a system supports the species tested.
It must also produce clinically useful complete blood count (CBC) parameters and deliver reliable results across relevant sample types and workloads.
This guide examines blood cell analyzers veterinary laboratories and clinics may consider, focusing on species-specific settings, red and white blood cell measurements, platelet counts, and practical performance considerations.
Use it to identify the capabilities that matter most before comparing instruments or requesting validation data. Prioritize documented performance in your species and samples over parameter counts alone.

Start with your laboratory’s species mix, including low-volume patients and referral cases. A system calibrated for dogs and cats may not reliably classify cells from other animals.
Ask the manufacturer for a current list of supported species, the available analysis mode for each, and the evidence behind every claimed measurement.
Separate species with validated quantitative results from those offered under a research, generic, or screening mode. Confirm which parameters are reported, suppressed, or flagged in each mode.
For example, a device may report a total white blood cell count for a species while providing no validated automated differential. Your workflow must account for that limitation.
Species-specific reference intervals are a separate requirement. Determine whether intervals are supplied, where they originated, and whether your laboratory can enter or verify its own intervals.
Also check whether age, breed, health status, and collection conditions affect interpretation. A manufacturer’s interval should not automatically replace local verification or appropriate published veterinary references.
For mixed-animal practices, estimate how often each species is tested and how often samples would require manual review or referral. This reveals the practical value of broad species coverage.
A useful comparison begins with clinical questions, not the longest parameter list. Map each reported value to the decisions your veterinarians or laboratory clients need to make.
For red blood cells, assess the availability of red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration.
These measurements help characterize anemia and other erythrocyte abnormalities, but their usefulness depends on accurate measurement and appropriate species-specific interpretation.
Clarify which values are directly measured and which are calculated. Errors in an underlying measurement can affect derived indices and create misleading patterns.
If reticulocyte analysis matters, check whether the analyzer provides an absolute reticulocyte count and whether that result is validated for the species you test.
In cats, ask how the system handles aggregate and punctate reticulocytes, and whether its output supports your laboratory’s preferred interpretation and reporting practice.
For white blood cells, compare the total leukocyte count and the reported differential. A five-part differential generally separates neutrophils, lymphocytes, monocytes, eosinophils, and basophils.
A three-part differential groups some cell populations together. It may suit routine screening, but it provides less detail and can increase the need for blood smear review.
Request performance data for abnormal samples, not just healthy controls. Leukopenia, leukocytosis, immature cells, and unusual cell morphology can challenge automated classification.
For platelets, assess the reported count, the measurement method, relevant flags, and the instrument’s handling of low counts. These details matter more than the parameter name alone.
Large platelets and platelet clumps can distort automated counts, particularly in feline samples. Establish when a smear estimate or an alternative method is required.
Ask whether the analyzer reports platelet indices and whether those indices are validated for your species. A displayed value is not necessarily supported for clinical interpretation.
Veterinary blood varies substantially in cell size and morphology. These differences can cause cell populations to overlap, making counting and classification more difficult.
Cats frequently present platelet clumping, while some breeds have unusually large platelets. An analyzer may underestimate the count or confuse large platelets with red cells.
In horses, leukocyte characteristics and sample handling can affect differential results. Review the manufacturer’s equine evidence rather than assuming canine performance transfers directly.
Ruminant samples may contain small red blood cells that complicate separation from platelets. Ask for validation data covering the particular species and count ranges you encounter.
Birds and many reptiles have nucleated red blood cells and thrombocytes. Instruments designed around mammalian cell characteristics may misclassify these cells or produce unreliable leukocyte counts.
For exotic species, confirm whether the system has a validated method for correcting or distinguishing nucleated cells. Otherwise, plan for manual methods or referral testing.
Do not assume that selecting a species name changes every relevant analytical setting. Request documentation describing calibration, algorithms, reportable parameters, and known interferences for that mode.
Ask suppliers for species-specific method comparison data against an appropriate reference method. Review the number of samples, clinical diversity, concentration ranges, and the comparator used.
A correlation coefficient alone is insufficient. Examine bias, agreement, and performance at clinically important decision points, especially for low platelet counts or severe leukopenia.
For differentials, request comparisons with a qualified manual differential and details of smear review procedures. Manual counts also have sampling variability, so interpret agreement accordingly.
Review precision using repeated measurements at normal and abnormal levels. Ask for within-run and between-run results and check whether they meet your laboratory’s quality goals.
Confirm the analyzer’s reportable range for each key parameter and species. A system may flag results outside its validated range instead of reporting a reliable numeric value.
Carryover matters when a sample with an extreme count follows a low-count sample. Ask how carryover was evaluated and whether additional cleaning is needed.
Flags should be assessed alongside numeric accuracy. Determine which abnormalities trigger a flag, how often flags occur, and whether the instrument provides histograms or scatterplots for review.
During an on-site evaluation, include abnormal, low-count, and species-representative specimens when available. Compare results with your established method and investigate discrepancies using predefined criteria.
Document acceptance limits before testing. Involve the laboratory director or supervising veterinarian in deciding which differences are clinically significant and when manual review is mandatory.
Compare the minimum required sample volume with the volumes you can routinely collect. Small patients may benefit from lower-volume testing, but confirm the actual aspiration and dead-volume requirements.
Check validated anticoagulants and collection tubes for each species. EDTA is common for mammalian CBCs, but suitability can vary, particularly for some avian and exotic specimens.
Ask about mixing, sample age, transport temperature, and time from collection to analysis. Delays can alter cell morphology and affect counts, differentials, and smear interpretation.
Evaluate throughput in the context of your real workload. Advertised tests per hour may exclude mixing, maintenance, quality control, repeat testing, and flagged-sample review.
For emergency settings, measure practical turnaround time from sample receipt to an actionable report. Include startup time, reagent readiness, and operator availability outside normal hours.
Review the frequency of cleaning, calibration, and quality control. Determine whether controls cover relevant species or whether additional verification procedures will be needed.
Ask how the instrument handles clots, insufficient volume, and instrument errors. Clear alerts and accessible troubleshooting can prevent delays and reduce unnecessary repeat collections.
Integration also matters. Confirm whether patient identifiers, species, results, flags, and images or graphs transfer correctly to your laboratory or practice management system.
Compare total ownership costs over a defined period, not just the purchase price. Use your expected monthly volume and species mix to build comparable estimates.
Include reagents, controls, calibrators, consumables, maintenance, software, connectivity, service contracts, and operator training. Account for reagent expiration and minimum order quantities.
Calculate the cost of repeat tests, manual differentials, and referral samples. A lower instrument price may be offset by a high review rate in your patient population.
Ask whether reagents are proprietary, how long opened packs remain stable, and what happens if a supply is interrupted. Confirm local availability and delivery lead times.
For service planning, check response times, remote support, loaner availability, and the cost of repairs outside the contract. These factors affect operational continuity.
Estimate cost per reportable CBC by dividing total relevant costs by the number of usable reports, including the effect of failed runs and necessary repeats.
Give each supplier the same species list, expected workload, and priority parameters. Request written responses so that claims can be compared consistently.
Ask for species-specific validation summaries, reportable ranges, precision data, method comparisons, interference information, and examples of flags and result displays.
Request instructions for use, maintenance schedules, quality control requirements, reagent stability, and a detailed quotation. Verify that the proposed configuration includes all necessary accessories.
Arrange a demonstration with your own representative samples where feasible. Include a process for resolving discrepancies and reviewing smears with qualified personnel.
Before acceptance, document installation checks, staff training, quality control procedures, and laboratory-defined verification criteria. Confirm who is responsible for each activity and its cost.
The best veterinary hematology analyzer is the one that supports your actual species and clinical questions with evidence you can evaluate.
Prioritize validated CBC parameters, reliable performance at decision points, and a workable plan for flags and manual review. Then compare workflow, service, and lifetime costs.
A structured evaluation turns a specification sheet into a defensible purchasing decision and helps your laboratory deliver results clinicians can use with confidence.
Have questions about the global trade trends discussed here, or planning your expansion and supply chain strategy? Leave a message below and let the trade experts at AMDS guide you.
“We respect your privacy. Your information is strictly confidential.”
Recommended News
Related News
0000-00
0000-00
0000-00
0000-00
0000-00
0000-00
Weekly Insights
Stay ahead with our curated technology reports delivered every Monday.